Category: Peru
Peru: First South American lineage of monkeypox identified
The health authorities of Peru identified the first South American lineage of the virus that causes monkeypox, which has been designated B.1.6 by the International Scientific Committee “mpxv-lineages”, an official statement reported on Wednesday. More...
Preprint: MU B.1.621 the most resistant variant to convalescent and vaccinated sera to date
Here, we demonstrate that the Mu variant is highly resistant to sera from COVID-19 convalescents and BNT162b2-vaccinated individuals. More...
Preprint: C.37 Lambda variant exhibits higher infectivity and immune resistance
“In this study, we demonstrated that three mutations, the RSYLTPGD246-253N, L452Q and F490S mutations, respectively confer resistance to the vaccine-induced antiviral immunity. More...
Preprint: Infectivity and immune escape of the new coronavirus variant of interest C.37 Lambda
“We also observed that the spike protein of the Lambda variant presented increased infectivity when compared with the spike protein of the Alpha and Gamma variants, both of them with reported increased infectivity and transmissibility. More...
Preprint: The emergence of Sars-CoV-2 coronavirus variant Lambda C.37 in South America
We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. More...
Peru: C.37 coronavirus variant named Lambda by WHO
The World Health Organization (WHO) said Wednesday that the coronavirus variant of COVID-19, commonly known as C.37, has been named Lambda. More...
Peru: Coronavirus death toll almost triples from 68,000 to 180,000, now worst in the world per capita
Peru said its Covid-19 death toll is actually almost three times as high as it had officially counted until now. More...
Peru: 40% of coronavirus cases in Lima are caused by the P.1 Brazilian variant
Approximately 40% of cases of the new coronavirus in Lima have been due to the P.1 Brazilian variant of this disease, according to a study carried out by the Peruvian National Institute of Health (INS). More...
AstraZeneca’s U.S. trial shows coronavirus vaccine is 79% effective
Preliminary results from a study examining the efficacy of the Oxford-AstraZeneca coronavirus vaccine indicate it is significantly effective at preventing severe illness from COVID-19. More...
UK donates 100 coronavirus ventilators for Peru’s COVID-19 patients
The Peruvian Ministry of Health on Friday received a donation of 60 mechanical and 40 multi-parameter ventilators from the United Kingdom of Great Britain and Northern Ireland. More...